Essen Coronary Artery Disease Registry (ECAD registry)

The ECAD registry is a registry of patients undergoing coronary angiography at the West German Heart and Vascular Center. The registry anticipates to determine predictors of patient outcome after coronary angiography.

Study Overview

• Status: Recruiting
• Conditions: Coronary Artery Disease

• Study Type: Observational
• Enrollment (Estimated): 55000

Contacts and Locations

• Study Contact: Name: Amir A Mahabadi, MD; Phone Number: 84822 +49 201 723; Email: amir-abbas.mahabadi@uk-essen.de
• Study Contact Backup: Name: Matthias Totzeck, MD; Phone Number: 84805 +49 201 723; Email: matthias.totzeck@uk-essen.de

Study Locations

• Germany
  • NRW
    • Essen, NRW, Germany, 45147
      • Recruiting
      • University Hospital Essen
      • Contact: Amir A Mahabadi, MD; Phone Number: 84822 +49201723; Email: amir-abbas.mahabadi@uk-essen.de

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

This registry includes all consecutive patients undergoing invasive coronary angiography at the West German Heart and Vascular Center, starting from 2003.

Description

Inclusion Criteria:

• Patients undergoing invasive coronary angiography at the West German Heart and Vascular Center

Exclusion Criteria:

• None

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort
Coronary angiography arm; Patient undergoing invasive coronary angiography

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
All-cause mortality	Mortality of any cause	through study completion, an average of 3 year

Collaborators and Investigators

• Sponsor: University Hospital, Essen
• Investigators: Principal Investigator: Tienush Rassaf, MD, University Hospital Essen, Deparment of Cardiology and Vascular Medicine

Study record dates

Study Major Dates

• Study Start (Actual): September 1, 2019
• Primary Completion (Estimated): December 30, 2026
• Study Completion (Estimated): June 30, 2027

Study Registration Dates

• First Submitted: December 5, 2019
• First Submitted That Met QC Criteria: December 10, 2019
• First Posted (Actual): December 12, 2019

Study Record Updates

• Last Update Posted (Actual): March 25, 2025
• Last Update Submitted That Met QC Criteria: December 18, 2024
• Last Verified: December 1, 2024

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Vascular Diseases; Cardiovascular Diseases; Heart Diseases; Arteriosclerosis; Arterial Occlusive Diseases; Coronary Artery Disease; Myocardial Ischemia; Coronary Disease
• Other Study ID Numbers: 19-8956-BO

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No